CAPTRUST Financial Advisors
SLDB icon

CAPTRUST Financial Advisors’s Solid Biosciences SLDB Stock Holding History

CAPTRUST Financial Advisors’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-254
Closed -$2K – 3731
2022
Q2 		$2K Hold
254
– – ﹤0.01% 4508
2022
Q1 		$5K Buy
+254
New +$4.48K ﹤0.01% 4168
2021
Q4 		– Sell
-10
Closed – – 4894
2021
Q3 		$0 Hold
10
– – ﹤0.01% 4746
2021
Q2 		$1K Hold
10
– – ﹤0.01% 4381
2021
Q1 		$1K Buy
+10
New +$1.11K ﹤0.01% 4234

Other funds holding SLDB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

CAPTRUST Financial Advisors's SLDB Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Solid Biosciences (SLDB) in Q3 2022, closing a stake of 254 shares — an estimated $2K sold.

CAPTRUST Financial Advisors first reported a position in SLDB in Q1 2021 and held it in 5 quarters. The position peaked at $5K in Q1 2022. 58 funds tracked by Wall St. Rank hold SLDB as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Solid Biosciences position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 254 Solid Biosciences shares in Q3 2022, an estimated $2K.
  • CAPTRUST Financial Advisors first reported a position in Solid Biosciences in Q1 2021 and held it in 5 quarters.
  • CAPTRUST Financial Advisors's Solid Biosciences position peaked at $5K in Q1 2022.
  • 58 funds tracked by Wall St. Rank held Solid Biosciences as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.